Author + information
- Do-Yoon Kang,
- Se Hun Kang,
- Ungjeong Do,
- Osung Kwon,
- Kyusup Lee,
- Jung Ae Hong,
- Pil Hyung Lee,
- Jung-Min Ahn,
- Duk-Woo Park,
- Soo-Jin Kang,
- Seung-Whan Lee,
- Young-Hak Kim and
- Cheol Whan Lee
Background: The patients with a prior history of stroke undergoing percutaneous coronary intervention (PCI) are increasing, but there are limited data about clinical outcomes.
Methods: The authors pooled patients-level data from 3 registry trials investigating clinical outcomes of CAD treated PCI with drug eluting stents (DES). The primary outcome of the study was death from any cause. The secondary outcomes were death from cardiac cause, myocardial infarction, stent thrombosis, stroke, or repeat revascularization.
Results: Of 18,650 patients included in the pooled dataset for whom treated PCI with DES, 1361 (7.3%) patients had history of stroke. Median follow-up time was 47.0 months (interquartile range: 31.5 to 57.4 months). Patients with prior stroke had a higher risk of death from any cause (adjusted hazard ratio [HR]: 1.623; 95% confidence interval [CI]: 1.342 to 1.962; P <0.001), death from cardiac cause (adjusted HR: 1.686; 95% CI: 1.339 to 2.124; P <0.001), and stroke (adjusted HR: 2.456; 95% CI: 1.853 to 3.255; P <0.001). There was no significant differences in the risk of myocardial infarction, stent thrombosis, or repeat revascularization.
Conclusions: Patients with stroke showed higher risk of all-cause death and stroke after PCI with DES than those without stroke. Meticulous medical management might be needed to improve prognosis in these patients after PCI with DES.
Moderated Poster Contributions
Acute and Stable Ischemic Heart Disease Moderated Poster Theater, Poster Hall, Hall C
Sunday, March 19, 2017, 10:00 a.m.-10:10 a.m.
Session Title: CAD in Unique Patient Populations
Abstract Category: 2. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number: 1309M-05
- 2017 American College of Cardiology Foundation